Sana Biotechnology, Inc. (SANA)

NASDAQ: SANA · Real-Time Price · USD

4.060

-0.300 (-6.88%)

At close: Jul 31, 2025, 4:00 PM

4.000

-0.060 (-1.48%)

After-hours: Jul 31, 2025, 7:15 PM EDT

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Market Capitalization	916	364	804	750	2,833	-	Upgrade
Market Cap Growth	-82.85%	-54.75%	7.21%	-73.52%	-	-	Upgrade
Enterprise Value	902	261	633	350	2,066	-	Upgrade
Last Close Price	4.06	1.63	4.08	3.95	15.48	-	Upgrade
PB Ratio	4.38	1.45	2.80	1.50	3.89	-	Upgrade
P/TBV Ratio	98.93	7.18	9.17	2.51	5.36	-	Upgrade
Debt / Equity Ratio	0.44	0.41	0.36	0.22	0.15	0.17	Upgrade
Quick Ratio	3.16	3.36	3.18	3.80	5.55	12.03	Upgrade
Current Ratio	3.40	3.54	3.31	3.99	5.62	12.22	Upgrade
Return on Equity (ROE)	-71.44%	-99.17%	-72.00%	-43.90%	-61.36%	-80.76%	Upgrade
Return on Assets (ROA)	-23.84%	-31.82%	-29.44%	-17.38%	-21.85%	-28.41%	Upgrade
Return on Capital (ROIC)	-34.37%	-45.61%	-40.90%	-23.45%	-30.25%	-39.39%	Upgrade
Earnings Yield	-22.79%	-73.30%	-35.22%	-35.92%	-12.56%	-	Upgrade
FCF Yield	-24.45%	-70.50%	-34.02%	-41.45%	-9.91%	-	Upgrade
Buyback Yield / Dilution	-17.36%	-18.68%	-3.29%	-13.16%	-1178.88%	-165.43%	Upgrade

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q